Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion

Molecular Oncology

Volumn 6, Issue 5, 2012, Pages 507-515

  Ao, Junping ^a   Meng, Jiao ^a   Zhu, Lei ^a   Nie, Huizhen ^a   Yang, Chenchen ^b   Li, Jinjun ^a   Gu, Jianren ^a   Lin, Qiushi ^c   Long, Weiwen ^d   Dong, Xiaoqun ^e   Li, Chao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Androgen receptor; Antagonist; Cell migration and invasion; Hepatocellular carcinoma; ID1; Metastasis

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; INHIBITOR OF DIFFERENTIATION 1; SHORT HAIRPIN RNA;

ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE SILENCING; LENTIVIRINAE; LIVER CELL CARCINOMA; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84866025643     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.06.005     Document Type: Article

References (31)

1. Groupe d'Etude et de Traitement du Carcinome H'epatocellulaire (GRETCH) Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen. Hepatology 2004, 40(6):1361-1369.
2. Abelev G.I., Eraiser T.L. Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin. Cancer Biol. 1999, 9(2):95-107.
3. Chiu C.M., Yeh S.H., et al. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc. Natl. Acad. Sci. USA 2007, 104(8):2571-2578.
4. Ciarrocchi A., Piana S., et al. Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cells. Eur. J. Cancer 2011, 47(6):934-945.
5. De Maria N., Manno M., et al. Sex hormones and liver cancer. Mol. Cell Endocrinol. 2002, 193(1-2):59-63.
6. Desprez P.Y., Sumida T., et al. Helix-loop-helix proteins in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 2003, 8(2):225-239.
7. Gomaa A.I., Khan S.A., et al. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J. Gastroenterol. 2008, 14(27):4300-4308.
8. Gorayski P., Thompson C.H., et al. Hepatocellular carcinoma associated with recreational anabolic steroid use. Br. J. Sports Med. 2008, 42(1):74-75. discussion 75.
9. Heinlein C.A., Chang C. Androgen receptor in prostate cancer. Endocr. Rev. 2004, 25(2):276-308.
10. Johnson P.J. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1999, 14(Suppl.):S32-S36.
11. Kalra M., Mayes J., et al. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J. Gastroenterol. 2008, 14(39):5945-5961.
12. Lee J.S., Thorgeirsson S.S. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology 2002, 35(5):1134-1143.
13. Lee T.K., Poon R.T., et al. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma. Clin. Cancer Res. 2006, 12(23):6910-6919.
14. Li C., Liang Y.Y., et al. Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover. Mol. Cell 2008, 31(6):835-849.
15. Li Z., Tuteja G., et al. Foxa1 and foxa2 are essential for sexual dimorphism in liver cancer. Cell 2012, 148(1-2):72-83.
16. Ma W.L., Hsu C.L., et al. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 2008, 135(3):947-955. 955 e941-945.
17. Mangelsdorf D.J., Thummel C., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83(6):835-839.
18. Martin N.M., Abu Dayyeh B.K., et al. Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage. World J. Gastroenterol. 2008, 14(28):4573-4575.
19. Minn A.J., Gupta G.P., et al. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436(7050):518-524.
20. Nagasue N., Yu L., et al. Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br. J. Surg. 1995, 82(4):542-547.
21. Naugler W.E., Sakurai T., et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317(5834):121-124.
22. Ramachandran B., Stell A., et al. Novel insights on imaging sex-hormone-dependent tumourigenesis in vivo. Endocr. Relat. Cancer 2011, 18(3):R41-R51.
23. Ruzinova M.B., Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 2003, 13(8):410-418.
24. Shang Y., Myers M., et al. Formation of the androgen receptor transcription complex. Mol. Cell 2002, 9(3):601-610.
25. Shirabe K., Takenaka K., et al. Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection. J. Surg. Oncol. 1997, 64(2):143-146.
26. Socas L., Zumbado M., et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br. J. Sports Med. 2005, 39(5):e27.
27. Tang Z.Y., Ye S.L., et al. A decade's studies on metastasis of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2004, 130(4):187-196.
28. Tejura S., Rodgers G.R., et al. Sex-steroid receptors in the diethylnitrosamine model of hepatocarcinogenesis: modifications by gonadal ablation and steroid replacement therapy. J. Mol. Endocrinol. 1989, 3(3):229-237.
29. Tsai M.J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 1994, 63:451-486.
30. Wang S.H., Yeh S.H., et al. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 2009, 50(5):1392-1402.
31. Yeh S.H., Chen P.J. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 2010, 78(Suppl. 1):172-179.